文献
J-GLOBAL ID:201902251405746816
整理番号:19A1968101
[2-11C]アセトンによる(R,S)-ノルエピネフリンの還元アルキル化を経由する11C標識PETトレーサとしてのタウ凝集阻害剤(R,S)-イソプロテレノールの合成【JST・京大機械翻訳】
Synthesis of (R,S)-isoproterenol, an inhibitor of tau aggregation, as an 11C-labeled PET tracer via reductive alkylation of (R,S)-norepinephrine with [2-11C]acetone
著者 (13件):
Ikenuma Hiroshi
(Field of Biological Molecular Sciences, United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan)
,
Ikenuma Hiroshi
(Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, 7-430 Morioka-cho, Obu-shi, Aichi 474-8511, Japan)
,
Koyama Hiroko
(Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan)
,
Kajino Naoya
(Division of Regeneration and Advanced Medical Science, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan)
,
Kimura Yasuyuki
(Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, 7-430 Morioka-cho, Obu-shi, Aichi 474-8511, Japan)
,
Ogata Aya
(Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, 7-430 Morioka-cho, Obu-shi, Aichi 474-8511, Japan)
,
Abe Junichiro
(Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, 7-430 Morioka-cho, Obu-shi, Aichi 474-8511, Japan)
,
Kawasumi Yasuhiro
(Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, 7-430 Morioka-cho, Obu-shi, Aichi 474-8511, Japan)
,
Kato Takashi
(Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, 7-430 Morioka-cho, Obu-shi, Aichi 474-8511, Japan)
,
Takashima Akihiko
(Department of Aging Neurobiology in Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu-shi, Aichi 474-8511, Japan)
,
Takashima Akihiko
(Department of Alzheimer’s Disease, Faculty of Life Science, Gakushuin University, Toshima-ku, Tokyo 171-8588, Japan)
,
Ito Kengo
(Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, 7-430 Morioka-cho, Obu-shi, Aichi 474-8511, Japan)
,
Suzuki Masaaki
(Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, 7-430 Morioka-cho, Obu-shi, Aichi 474-8511, Japan)
資料名:
Bioorganic & Medicinal Chemistry Letters
(Bioorganic & Medicinal Chemistry Letters)
巻:
29
号:
16
ページ:
2107-2111
発行年:
2019年
JST資料番号:
W0248A
ISSN:
0960-894X
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
オランダ (NLD)
言語:
英語 (EN)